vastinor tablet 10mg
xepa-soul pattinson (malaysia) sdn bhd - rosuvastatin calcium -
vastinor tablet 20mg
xepa-soul pattinson (malaysia) sdn bhd - rosuvastatin calcium -
mavenclad 10 mg tablets
merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features
mavenclad 10 mg tablets
merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features
mavenclad tablet 10mg
merck pte. ltd. - cladribine - tablet - cladribine 10mg
mavenclad
pharmacy retailing (nz) ltd t/a healthcare logistics - cladribine 10mg; - tablet - 10 mg - active: cladribine 10mg excipient: hydroxypropyl-beta-cyclodextrin magnesium stearate sorbitol water for injection - mavenclad is indicated for the treatment of relapsing-remitting multiple sclerosis (rrms) to reduce the frequency of clinical relapses and to delay the progression of physical disability. following completion of the two treatment courses, no further cladribine treatment is required in years three and four. re-initiation of therapy after year four has not been studied.
mavenclad tablet
emd serono, a division of emd inc., canada - cladribine - tablet - 10mg - cladribine 10mg - immunosuppressive agents
licotepin 12,5 mg filmtabletten
licotia 12,5 mg filmtabletten
tianeptin liconsa 12,5 mg filmtabletten